Working… Menu
Trial record 42 of 108 for:    CALCIUM CATION

Calcium Concentration in Bicarbonate Hemodialysis (HD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01353170
Recruitment Status : Completed
First Posted : May 12, 2011
Last Update Posted : May 12, 2011
Information provided by:
Miulli General Hospital

Brief Summary:
The study was designed in order to investigate the effects of 3 different dialysate calcium concentrations may exert on mineral metabolism and hemodynamic stability in standard hemodialysis (hd).

Condition or disease Intervention/treatment Phase
Calcium Mass Balances and Serum Calcium Profiling in hd Patients Other: Dialysate calcium concentration Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 22 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparison Among Different Dialysate Calcium Concentrations in Bicarbonate Hemodialysis
Study Start Date : January 2010
Actual Primary Completion Date : September 2010
Actual Study Completion Date : September 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Calcium Dialysis

Arm Intervention/treatment
Experimental: Prevalent hd patients
Patients undergoing three consecutive cross-over hd session with 3 different dialysate calcium concentrations
Other: Dialysate calcium concentration
Calcium dialysate concentrations: 1.25, 1.35 and 1.5 mmol/l

Primary Outcome Measures :
  1. Serum calcium concentrations [ Time Frame: 4 hours ]
    Evaluation of calcium mass balances and ionized calcium serum concentrations profiling during three hd sessions with different calcium concentrations in the dialysate

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • bicarbonate hd since 6 months
  • uncomplicated hd sessions

Exclusion Criteria:

  • Incident patients
  • unstable hd patients
  • patients aged less than 18 years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01353170

Layout table for location information
Nephrology and dialysis unit Miulli General Hospital
Acquaviva delle Fonti, Bari, Italy, 70100
Sponsors and Collaborators
Miulli General Hospital

Layout table for additonal information
Responsible Party: Carlo Basile M D, Miulli GH Identifier: NCT01353170     History of Changes
Other Study ID Numbers: Basile calcium
First Posted: May 12, 2011    Key Record Dates
Last Update Posted: May 12, 2011
Last Verified: December 2010
Keywords provided by Miulli General Hospital:
Serum calcium
Mass balance
Blood pressure
Additional relevant MeSH terms:
Layout table for MeSH terms
Calcium, Dietary
Dialysis Solutions
Calcium-Regulating Hormones and Agents
Physiological Effects of Drugs
Bone Density Conservation Agents
Pharmaceutical Solutions